Skip to main content
Top
Published in: Medical Oncology 5/2018

01-05-2018 | Original Paper

Characteristics and survival outcomes associated with the lack of radiation in the treatment of glioblastoma

Authors: Bin Huang, Therese A. Dolecek, Quan Chen, Catherine R. Garcia, Thomas Pittman, John L. Villano

Published in: Medical Oncology | Issue 5/2018

Login to get access

Abstract

Radiation increases survival in glioblastoma (GBM); however, 30% do not receive this treatment. We sought to identify characteristics associated with not receiving radiation and the impact on outcomes. We analyzed the Surveillance, Epidemiology, and End Results program (SEER) 18 registries 2000–2013 research database on 30,479 GBM cases that were aged 20 years and older. In total, 21,179 received radiation as first course of therapy, while 8218 did not with 5178 (63%) being 65 years and older. Early decisions on surgery often predicted radiation therapy with 61% having only a biopsy or no surgery at diagnosis. Radiation use as upfront therapy has slowly increased over time at a rate of 0.4% per year; still 25% did not receive radiation in 2013. Cases treated with radiation were more likely to be younger, underwent surgery, lived in a metropolitan area, had higher socioeconomic status, and were in a couple-based relationship. An increased survival in GBM was associated with the use of upfront radiation along with younger age, being of race other than white, undergoing surgery, and a more recent diagnosis. Not receiving radiation therapy adversely affects survival. A trend toward an increased use of radiation was observed although many young adults still do not receive this treatment. Decreased usage of radiation in the elderly and in biopsy-only surgeries was anticipated, but race, gender, and poverty were also statistically significant. Clinicians should be aware of this underutilization, and an increased usage of radiation should improve outcomes for glioblastoma.
Literature
1.
go back to reference Curry WT Jr, Barker FG 2nd. Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol. 2009;93(1):25–39.CrossRefPubMed Curry WT Jr, Barker FG 2nd. Racial, ethnic and socioeconomic disparities in the treatment of brain tumors. J Neurooncol. 2009;93(1):25–39.CrossRefPubMed
2.
go back to reference Daly B, Olopade OI. A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin. 2015;65(3):221–38.CrossRefPubMed Daly B, Olopade OI. A perfect storm: how tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change. CA Cancer J Clin. 2015;65(3):221–38.CrossRefPubMed
3.
go back to reference Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78–93.CrossRefPubMed Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78–93.CrossRefPubMed
4.
go back to reference Koshy M, Villano JL, Dolecek TA, Howard A, Mahmood U, Chmura SJ, et al. Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neuro oncol. 2012;107(1):207–12.CrossRef Koshy M, Villano JL, Dolecek TA, Howard A, Mahmood U, Chmura SJ, et al. Improved survival time trends for glioblastoma using the SEER 17 population-based registries. J Neuro oncol. 2012;107(1):207–12.CrossRef
5.
go back to reference Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459–66.CrossRefPubMed Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009;10(5):459–66.CrossRefPubMed
6.
go back to reference Mukherjee D, Zaidi HA, Kosztowski T, Chaichana KL, Brem H, Chang DC, et al. Disparities in access to neuro-oncologic care in the United States. Arch Surg (Chicago, Ill: 1960). 2010;145(3):247–53.CrossRef Mukherjee D, Zaidi HA, Kosztowski T, Chaichana KL, Brem H, Chang DC, et al. Disparities in access to neuro-oncologic care in the United States. Arch Surg (Chicago, Ill: 1960). 2010;145(3):247–53.CrossRef
7.
go back to reference Mukherjee D, Patil CG, Todnem N, Ugiliweneza B, Nuno M, Kinsman M, et al. Racial disparities in Medicaid patients after brain tumor surgery. J Clin Neurosci Off J Neurosurg Soc Australas. 2013;20(1):57–61. Mukherjee D, Patil CG, Todnem N, Ugiliweneza B, Nuno M, Kinsman M, et al. Racial disparities in Medicaid patients after brain tumor surgery. J Clin Neurosci Off J Neurosurg Soc Australas. 2013;20(1):57–61.
8.
go back to reference Robertson JT, Gunter BC, Somes GW. Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee. Br J Neurosurg. 2002;16(6):562–6.CrossRefPubMed Robertson JT, Gunter BC, Somes GW. Racial differences in the incidence of gliomas: a retrospective study from Memphis, Tennessee. Br J Neurosurg. 2002;16(6):562–6.CrossRefPubMed
9.
go back to reference Aizer AA, Ancukiewicz M, Nguyen PL, Shih HA, Loeffler JS, Oh KS. Underutilization of radiation therapy in patients with glioblastoma: predictive factors and outcomes. Cancer. 2014;120(2):238–43.CrossRefPubMed Aizer AA, Ancukiewicz M, Nguyen PL, Shih HA, Loeffler JS, Oh KS. Underutilization of radiation therapy in patients with glioblastoma: predictive factors and outcomes. Cancer. 2014;120(2):238–43.CrossRefPubMed
10.
go back to reference Aneja S, Khullar D, Yu JB. The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme. J Neurooncol. 2013;112(3):393–401.CrossRefPubMedPubMedCentral Aneja S, Khullar D, Yu JB. The influence of regional health system characteristics on the surgical management and receipt of post operative radiation therapy for glioblastoma multiforme. J Neurooncol. 2013;112(3):393–401.CrossRefPubMedPubMedCentral
11.
go back to reference Rusthoven CG, Carlson JA, Waxweiler TV, Dally MJ, Baron AE, Yeh N, et al. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population. Int J Radiat Oncol Biol Phys. 2014;90(4):894–902.CrossRefPubMed Rusthoven CG, Carlson JA, Waxweiler TV, Dally MJ, Baron AE, Yeh N, et al. The impact of adjuvant radiation therapy for high-grade gliomas by histology in the United States population. Int J Radiat Oncol Biol Phys. 2014;90(4):894–902.CrossRefPubMed
12.
go back to reference Shen X, Showalter TN, Mishra MV, Barth S, Rao V, Levin D, et al. Radiation oncology services in the modern era: evolving patterns of usage and payments in the office setting for medicare patients from 2000 to 2010. J Oncol Pract. 2014;10(4):e201–7.CrossRefPubMed Shen X, Showalter TN, Mishra MV, Barth S, Rao V, Levin D, et al. Radiation oncology services in the modern era: evolving patterns of usage and payments in the office setting for medicare patients from 2000 to 2010. J Oncol Pract. 2014;10(4):e201–7.CrossRefPubMed
13.
go back to reference Kalbasi A, Swisher-McClure S, Mitra N, Sunderland R, Smaldone MC, Uzzo RG, et al. Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features. Cancer. 2014;120(19):3089–96.CrossRefPubMedPubMedCentral Kalbasi A, Swisher-McClure S, Mitra N, Sunderland R, Smaldone MC, Uzzo RG, et al. Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features. Cancer. 2014;120(19):3089–96.CrossRefPubMedPubMedCentral
14.
go back to reference Monson JR, Probst CP, Wexner SD, Remzi FH, Fleshman JW, Garcia-Aguilar J, et al. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg. 2014;260(4):625–31.CrossRefPubMed Monson JR, Probst CP, Wexner SD, Remzi FH, Fleshman JW, Garcia-Aguilar J, et al. Failure of evidence-based cancer care in the United States: the association between rectal cancer treatment, cancer center volume, and geography. Ann Surg. 2014;260(4):625–31.CrossRefPubMed
15.
go back to reference Eifel PJ, Ho A, Khalid N, Erickson B, Owen J. Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study. Int J Radiat Oncol Biol Phys. 2014;89(2):249–56.CrossRefPubMed Eifel PJ, Ho A, Khalid N, Erickson B, Owen J. Patterns of radiation therapy practice for patients treated for intact cervical cancer in 2005 to 2007: a quality research in radiation oncology study. Int J Radiat Oncol Biol Phys. 2014;89(2):249–56.CrossRefPubMed
16.
go back to reference Lin JF, Berger JL, Krivak TC, Beriwal S, Chan JK, Sukumvanich P, et al. Impact of facility volume on therapy and survival for locally advanced cervical cancer. Gynecol Oncol. 2014;132(2):416–22.CrossRefPubMed Lin JF, Berger JL, Krivak TC, Beriwal S, Chan JK, Sukumvanich P, et al. Impact of facility volume on therapy and survival for locally advanced cervical cancer. Gynecol Oncol. 2014;132(2):416–22.CrossRefPubMed
17.
go back to reference Megwalu UC, Sikora AG. Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014;140(9):855–60.CrossRefPubMed Megwalu UC, Sikora AG. Survival outcomes in advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg. 2014;140(9):855–60.CrossRefPubMed
18.
go back to reference Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, et al. Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014;90(1):224–30.CrossRefPubMedPubMedCentral Wong J, Xu B, Yeung HN, Roeland EJ, Martinez ME, Le QT, et al. Age disparity in palliative radiation therapy among patients with advanced cancer. Int J Radiat Oncol Biol Phys. 2014;90(1):224–30.CrossRefPubMedPubMedCentral
19.
go back to reference Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al., editors. International classification of diseases for oncology: ICD-O. 3rd ed. Geneva: World Health Organization; 2000. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al., editors. International classification of diseases for oncology: ICD-O. 3rd ed. Geneva: World Health Organization; 2000.
21.
go back to reference Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, et al. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 2015;314(23):2535–43.CrossRefPubMed Stupp R, Taillibert S, Kanner AA, Kesari S, Steinberg DM, Toms SA, et al. Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial. JAMA. 2015;314(23):2535–43.CrossRefPubMed
22.
go back to reference Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 1978;49(3):333–43.CrossRefPubMed Walker MD, Alexander E Jr, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, et al. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg. 1978;49(3):333–43.CrossRefPubMed
23.
go back to reference Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, International agency for research on cancer (isb Herausgebendes Organ). WHO classification of tumours of the central nervous system. Revised 4th ed. ed2016, p. 408 Seiten. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, International agency for research on cancer (isb Herausgebendes Organ). WHO classification of tumours of the central nervous system. Revised 4th ed. ed2016, p. 408 Seiten.
24.
go back to reference Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(16):2563–9.CrossRef Mirimanoff RO, Gorlia T, Mason W, Van den Bent MJ, Kortmann RD, Fisher B, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial. J Clin Oncol Off J Am Soc Clin Oncol. 2006;24(16):2563–9.CrossRef
25.
go back to reference Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98–110.CrossRefPubMedPubMedCentral Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell. 2010;17(1):98–110.CrossRefPubMedPubMedCentral
26.
go back to reference Smoll NR, Schaller K, Gautschi OP. Long-term survival of patients with glioblastoma multiforme (GBM). J Clin Neurosci Off J Neurosurg Soc Australas. 2013;20(5):670–5. Smoll NR, Schaller K, Gautschi OP. Long-term survival of patients with glioblastoma multiforme (GBM). J Clin Neurosci Off J Neurosurg Soc Australas. 2013;20(5):670–5.
27.
go back to reference Breen N, Wesley MN, Merrill RM, Johnson K. The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the national cancer institute black-white cancer survival study. Ethn Dis. 1999;9(1):111–25.PubMed Breen N, Wesley MN, Merrill RM, Johnson K. The relationship of socio-economic status and access to minimum expected therapy among female breast cancer patients in the national cancer institute black-white cancer survival study. Ethn Dis. 1999;9(1):111–25.PubMed
28.
go back to reference Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(35):5570–7.CrossRef Owonikoko TK, Ragin CC, Belani CP, Oton AB, Gooding WE, Taioli E, et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol Off J Am Soc Clin Oncol. 2007;25(35):5570–7.CrossRef
29.
go back to reference Brandes AA, Franceschi E, Ermani M, Tosoni A, Albani F, Depenni R, et al. Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? Neurooncol Pract. 2014;1(4):166–71.PubMedPubMedCentral Brandes AA, Franceschi E, Ermani M, Tosoni A, Albani F, Depenni R, et al. Pattern of care and effectiveness of treatment for glioblastoma patients in the real world: Results from a prospective population-based registry. Could survival differ in a high-volume center? Neurooncol Pract. 2014;1(4):166–71.PubMedPubMedCentral
Metadata
Title
Characteristics and survival outcomes associated with the lack of radiation in the treatment of glioblastoma
Authors
Bin Huang
Therese A. Dolecek
Quan Chen
Catherine R. Garcia
Thomas Pittman
John L. Villano
Publication date
01-05-2018
Publisher
Springer US
Published in
Medical Oncology / Issue 5/2018
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-018-1134-3

Other articles of this Issue 5/2018

Medical Oncology 5/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine